Health Care Ultrasector Profund
Health Care Ultrasector Profund reported 59 holdings worth US$12.1M as of Jul 31, 2026 (Form N-PORT)
As of Jul 31, 2026 · Filed Sep 23, 2026
Health Care Ultrasector Profund reported 59 holdings worth US$12.1M as of Jul 31, 2026. Largest: Eli Lilly And Company, Johnson & Johnson and Abbvie Inc. Filed Sep 23, 2026 (Form N-PORT).
- Holdings
- 59
- Value as reported
- US$12.1M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Eli Lilly And Company | 1,245 | US$1.43M | 11.8% |
| Johnson & Johnson | 3,787 | US$971K | 8.0% |
| Abbvie Inc. | 2,780 | US$698K | 5.8% |
| Unitedhealth Group Incorporated | 1,429 | US$592K | 4.9% |
| Merck & Company, Inc. | 3,886 | US$506K | 4.2% |
| Thermo Fisher Scientific Inc | 585 | US$336K | 2.8% |
| Amgen Inc. | 849 | US$327K | 2.7% |
| Abbott Laboratories | 2,740 | US$290K | 2.4% |
| Gilead Sciences, Inc. | 1,953 | US$254K | 2.1% |
| Pfizer, Inc. | 8,967 | US$224K | 1.9% |
| Bristol-myers Squibb Company | 3,213 | US$210K | 1.7% |
| Cvs Health Corporation | 2,007 | US$210K | 1.7% |
| Intuitive Surgical, Inc. | 557 | US$197K | 1.6% |
| Danaher Corporation | 991 | US$193K | 1.6% |
| Vertex Pharmaceuticals Incorporated | 399 | US$190K | 1.6% |
| Stryker Corporation | 543 | US$177K | 1.5% |
| Medtronic Plc. | 2,020 | US$172K | 1.4% |
| Mckesson Corporation | 189 | US$162K | 1.3% |
| Elevance Health, Inc. | 342 | US$129K | 1.1% |
| Regeneron Pharmaceuticals, Inc. | 157 | US$120K | 0.99% |
| The Cigna Group | 416 | US$116K | 0.96% |
| Boston Scientific Corporation | 2,339 | US$109K | 0.90% |
| Hca Healthcare, Inc. | 244 | US$98,232 | 0.81% |
| Cencora, Inc. | 306 | US$95,270 | 0.79% |
| Cardinal Health, Inc. | 368 | US$84,651 | 0.70% |
| Edwards Lifesciences Corporation | 906 | US$77,979 | 0.65% |
| Becton, Dickinson And Company | 434 | US$71,879 | 0.59% |
| Idexx Laboratories, Inc. | 124 | US$69,325 | 0.57% |
| Humana Inc. | 189 | US$68,770 | 0.57% |
| Iqvia Holdings, Inc. | 263 | US$61,810 | 0.51% |
| Agilent Technologies, Inc. | 445 | US$61,575 | 0.51% |
| Waters Corporation | 154 | US$58,106 | 0.48% |
| Zoetis Inc. | 660 | US$51,011 | 0.42% |
| Dexcom, Inc. | 607 | US$50,654 | 0.42% |
| Ge Healthcare Technologies Inc. | 716 | US$48,702 | 0.40% |
| Resmed Inc. | 228 | US$48,103 | 0.40% |
| Veeva Systems Inc. | 236 | US$48,092 | 0.40% |
| Biogen Inc. | 232 | US$47,084 | 0.39% |
| Centene Corporation | 738 | US$45,918 | 0.38% |
| Mettler-toledo International, Inc. | 32 | US$45,322 | 0.37% |
| Quest Diagnostics Incorporated | 174 | US$40,544 | 0.34% |
| Labcorp Holdings Inc. | 129 | US$39,887 | 0.33% |
| West Pharmaceutical Services, Inc. | 111 | US$37,847 | 0.31% |
| Steris Plc (ireland) | 154 | US$35,174 | 0.29% |
| Viatris Inc. | 1,832 | US$32,170 | 0.27% |
| Incyte Corporation | 264 | US$31,553 | 0.26% |
| Moderna, Inc. | 556 | US$30,480 | 0.25% |
| Zimmer Biomet Holdings, Inc. | 304 | US$28,555 | 0.24% |
| The Cooper Companies, Inc. | 307 | US$22,202 | 0.18% |
| Baxter International Inc. | 813 | US$21,268 | 0.18% |
| Solventum Corporation | 232 | US$19,822 | 0.16% |
| Revvity, Inc. | 176 | US$19,804 | 0.16% |
| Insulet Corporation | 109 | US$18,023 | 0.15% |
| Align Technology, Inc. | 105 | US$17,762 | 0.15% |
| Bio-techne Corp | 246 | US$17,734 | 0.15% |
| Charles River Laboratories International, Inc. | 76 | US$17,671 | 0.15% |
| Universal Health Services, Inc. | 84 | US$14,149 | 0.12% |
| Henry Schein, Inc. | 152 | US$13,034 | 0.11% |
| Davita Inc. | 51 | US$12,245 | 0.10% |
Source
View original at SEC
Related